Darnitsa exports 22 brands to Armenia

Now the pharmaceutical company "Darnitsa" exports medicaments of its own production to 15 countries of the EU, CIS, Near (Middle) East, North Africa and the Asia-Pacific region. The company also intends to develop new export directions, in particular, the Latin American markets.

Today we are presenting you the export to the Armenian market. Darnitsa exports 22 brands and 24 SKUs to this market.

The largest brand in monetary terms is Levomycetin-Darnitsa * (tablets); in packages - Validol-Darnitsa medicament ** (tablets). The company is present in 6 therapeutic groups. The largest group in monetary terms is group (J) antimicrobials for systemic use. It is represented by such medicaments as Levomycetin-Darnitsa and Isoniazid-Darnitsa * * * on the Armenian market. In the packages, the largest group is the group of cardiological medicaments (C01), represented by the medicament Validol-Darnitsa (tablets), and also the group of antihistamines (R06), represented by the medicament Diazolin-Darnitsa.

Reference

PJSC pharmaceutical company "Darnitsa" was founded in 1930. Since 1998, Darnitsa has been the leader in Ukraine in terms of the volume of production of medicines in kind. The strategic directions of the portfolio development are cardiology, neurology, and pain problem-solving. During 2015-2020, Darnitsa released 50 pharmaceutical brands to the market

* RP №UA/3470/01/02, UA/3470/01/01

** RP №UA/6366/01/01

*** RP №UA/2671/01/01

**** RP №UA/0278/01/01

***** The abovementioned information is intended exclusively for distribution in specialized publications dedicated to medical institutions and doctors, and also at conferences and seminars on medical topics.